Back to discover
Disease

Empyema, Pleural

Late-stage therapeutic developmentEmerging research
1
Publications
8
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections.

Research2023-11-01Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q3 2028.
Major developments

Clinical trials

6 sponsors · 1 new · 1 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
8
All trials
1
Active
3
Late-stage
5
Completed
Recruiting

Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema (ONLY ONCE)

Phase 4 · Recruiting · University of North Carolina, Chapel Hill
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 29 cites
Recent publications

Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 29 cites
Major themes4
  • Bacteremia1
  • Brain Abscess1
  • Communicable Diseases1
  • Empyema, Pleural1
Leading journals1
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1
Leading researchers8
  • Bø B1
  • Breistein R1
  • Dyrhovden R1
  • Eagan TM1
  • Fardal H1
  • Fløtten Ø1
  • Grøvan F1
  • Hjetland R1
Affiliations (unnormalised)6
  • Akershus University Hospital1
  • Department of Clinical Science1
  • Division of Medicine and Laboratory Sciences1
  • Førde Central Hospital1
  • Haraldsplass Deaconess Hospital1
  • Haukeland University Hospital1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Suppurative inflammation of the pleural space.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.